GF Fund Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$196K Sell
2,500
-141
-5% -$9.61K ﹤0.01% 278
2026
Q1
$171K Buy
2,641
+331
+14% +$23.3K ﹤0.01% 297
2025
Q4
$155K Sell
2,310
-206
-8% -$13.9K ﹤0.01% 313
2025
Q3
$185K Sell
2,516
-742
-23% -$49.3K ﹤0.01% 300
2025
Q2
$169K Hold
3,258
﹤0.01% 330
2025
Q1
$208K Buy
3,258
+587
+22% +$34.1K ﹤0.01% 315
2024
Q4
$128K Buy
+2,671
New +$137K ﹤0.01% 315

Other funds holding HALO

GF Fund Management's HALO Position: Q2 2026 in Review

GF Fund Management reduced its Halozyme (HALO) stake by 5.3% in Q2 2026, selling an estimated $9.61K and leaving 2,500 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

GF Fund Management first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. The position peaked at $208K in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • GF Fund Management held 2,500 shares of Halozyme worth $196K as of Q2 2026.
  • GF Fund Management sold 141 Halozyme shares in Q2 2026, an estimated $9.61K.
  • Halozyme made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #278 holding.
  • GF Fund Management first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Halozyme position peaked at $208K in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.